Abstract
The only currently available, potentially curative treatment of hepatic metastasis is resection. With a reported 5-year survival rate of 30% this has become an accepted treatment for this condition. An overview of clinical experience in prevention, early diagnosis, and selection criteria for and treatment of patients with liver metastasis in The Netherlands is given. Results indicate a slow but steady improvement in understanding the disease, with benefit for the patient.